Sort
10,766 grants matching “checkpoint inhibitor”
A Phase 2 study of a Checkpoint Inhibitor in Men with Progressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
$0Matthew B Rettig · Va Greater Los Angeles Healthcare System · I01 · FY2023 · VA
TELOMERASE ACTIVITY, TELOMERE FUNCTION, CHROMOSOME STABI
$0Johns Hopkins University · P01 · FY2002 · CA
TELOMERASE ACTIVITY, TELOMERE FUNCTION, CHROMOSOME STABI
$0Johns Hopkins University · P01 · FY2002 · CA
Design of Drugs Against Cancer and Viral Diseases
$0Basic Sciences · Z01 · FY2001 · BC
Mechanisms of G2/M cell cycle checkpoint controls
$0Basic Sciences · Z01 · FY2001 · BC
Combining Immune Therapy with Targeted Therapies to Improve Melanoma Survival
$0Ann Richmond · Veterans Health Administration · I01 · FY2023 · VA
GRP78/BIP PATHWAYS IN ANTITUMOR DRUG RESPONSE
$0St. Jude Children'S Research Hospital · P01 · FY2002 · CA
Combined inhibition of PLK1 and NOTCH for melanoma management
$0Nihal Ahmad · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2024 · VA
BCCMA: Translational research to improve the care of advanced bladder cancer
$0Chong-Xian Pan · Va Boston Health Care System · I01 · FY2024 · VA
BLRD Research Career Scientist Award Application
$0Sushanta K Banerjee · Kansas City Va Medical Center · IK6 · FY2024 · VA
Protein Kinase Antagonists: Preclinical and Clinical
$0Clinical Sciences · Z01 · FY2000 · SC
DESIGN OF DRUG AGAINST CANCER AND VIRAL DISEASES
$0Basic Sciences · Z01 · FY2000 · BC
MECHANISMS OF G2 / M CELL CYCLE CHECKPOINT CONTROLS
$0Basic Sciences · Z01 · FY2000 · BC
Molecular Mechanisms Of Human Retrovirus Trans-regulator
$0Niaid Extramural Activities · Z01 · FY2002 · AI
Glycocalyx Targeting and Augmenting Cellular Immunity in Lung Cancer
$0Mark M Fuster · Va San Diego Healthcare System · I01 · FY2022 · VA
Double-strand Breaks And Untargeted Dna Metabolic Events
$0Environmental Health Sciences · Z01 · FY2004 · ES
Melanoma Resistance to Apoptosis: Mechanisms and Therapeutic Potential
$0David A. Norris · Va Eastern Colorado Health Care System · I01 · FY2020 · VA
Genome Instability in Cancer Development
$0Human Genome Research · Z01 · FY2004 · HG
Melanoma Resistance to Apoptosis: Mechanisms and Therapeutic Potential
$0David A. Norris · Va Eastern Colorado Health Care System · I01 · FY2022 · VA
ISOLATION OF NOVEL MECHANISM-BASED ANTITUMOR AGENTS
$0University Of Virginia Charlottesville · U19 · FY2002 · CA
The Molecular Mechanism Of Cell Cycle Regulation In Budd
$0Diabetes, Digestive, Kidney Diseases · Z01 · FY2003 · DK
Potentiation of Immunotherapy with targeted nanoporphyrin in bladder cancer
$0Chong-Xian Pan · Va Boston Health Care System · I01 · FY2020 · VA
Death Receptors In Immune Cell Homeostasis
$0Arthritis, Musculoskeletal, Skin Dis · Z01 · FY2003 · AR
Mechanisms Of Nucleic Acid Enzymes--pol Beta And Mammali
$0Environmental Health Sciences · Z01 · FY2003 · ES
Melanoma Resistance to Apoptosis: Mechanisms and Therapeutic Potential
$0David A. Norris · Va Eastern Colorado Health Care System · I01 · FY2021 · VA